6 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 7.4% per year over the past 5 years.
Operating margin has contracted, at -4297.0% in the latest year.
Financial health
Total debt has grown faster than revenue (4.2% vs -7.4% per year).
Operating income covered interest expense -575.7× in the latest year.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$3M
-$115M
0.0%
-4297.0%
-$94M
—
$20M
2024
$5M
-$103M
0.0%
-2401.6%
-$73M
$4M
$41M
2023
$6M
-$111M
0.0%
-2020.2%
-$65M
$8M
$72M
2022
$5M
-$105M
0.0%
-2357.0%
-$98M
$11M
$60M
2021
$4M
-$101M
0.0%
-1876.7%
-$99M
$4M
$253M
2020
$4M
-$14M
0.0%
-323.1%
-$13M
—
$70M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$215000
-$30M
0.0%
-14347.0%
-$26M
—
$9M
Dec '25
$650000
-$30M
0.0%
-4775.5%
-$29M
—
$20M
Sep '25
$378000
-$29M
0.0%
-7977.2%
-$26M
—
$9M
Jun '25
$593000
-$31M
0.0%
-5293.9%
-$17M
—
$38M
Mar '25
$1M
-$26M
0.0%
-2351.9%
-$22M
—
$47M
Dec '24
$665000
-$29M
0.0%
-4477.3%
-$17M
$4M
$41M
Sep '24
$2M
-$27M
0.0%
-1698.7%
-$21M
—
$38M
Jun '24
$1M
-$25M
0.0%
-2104.0%
-$17M
—
$43M
Mar '24
$898000
-$22M
0.0%
-2616.7%
-$18M
—
$59M
Dec '23
$338000
-$24M
0.0%
-7319.2%
-$15M
$8M
$72M
Sep '23
$744000
-$22M
0.0%
-3132.1%
-$11M
—
$70M
Jun '23
$3M
-$42M
0.0%
-1276.7%
-$19M
—
$61M
Mar '23
$1M
-$23M
0.0%
-1929.5%
-$20M
—
$11M
Dec '22
$1M
-$19M
0.0%
-1469.9%
-$19M
$11M
$60M
Sep '22
$2M
-$27M
0.0%
-1395.6%
-$24M
$9M
$107M
Jun '22
$636000
-$29M
0.0%
-4542.0%
-$26M
$9M
$206M
Mar '22
$454000
-$29M
0.0%
-6344.3%
-$28M
—
$226M
Dec '21
$1M
-$25M
0.0%
-2415.5%
-$25M
$4M
$253M
Sep '21
$1M
-$24M
0.0%
-1521.0%
-$27M
—
$279M
Jun '21
$592000
-$41M
0.0%
-2819.6%
-$32M
—
$99M
Valuation over time
How the market has priced ABSI against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 60.6× (Mar '23) to 569.3× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is ABSI growing its revenue and profit?
Over the past 5 years, Absci Corp's revenue has declined 7.4% per year. These are computed facts, not advice.
How much debt does ABSI have?
As of FY2025, Absci Corp reported — of total debt against $20M of cash; operating income covered interest expense -575.7×.
What is ABSI's profit margin?
In FY2025, gross margin was —, operating margin -4297.0%, and net margin -4113.7%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.